[1] |
Parikh S, Goldstein A, Koenig MK, et al. Diagnosis and management of mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society[J]. Genet Med, 2015, 17(9):689-701.
doi: 10.1038/gim.2014.177
pmid: 25503498
|
[2] |
Sharma R, Reinstadler B, Engelstad K, et al. Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity[J]. J Clin Invest, 2021, 131(2).
|
[3] |
Barca E, Long Y, Cooley V, et al. Mitochondrial diseases in North America: An analysis of the NAMDC registry[J]. Neurol Genet, 2020, 6(2):e402.
|
[4] |
Ng YS, Grady JP, Lax NZ, et al. Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: An unrecognized clinical entity in young, asymptomatic adults[J]. Eur Heart J, 2016, 37(32):2552-2559.
|
[5] |
杨倩, 符跃强. GTPBP3基因变异相关线粒体病1例报告并文献复习[J]. 临床儿科杂志, 2021, 39(11):818-821.
|
[6] |
赵晓旭, 吴雪怡, 许连军, 等. 核基因突变所致线粒体心肌病一例及文献复习[J]. 中国分子心脏病学杂志, 2021, 21(6):4387-4389.
|
[7] |
钱天维, 张璐彦, Omermujtaba M, 等. 线粒体tRNA变异致儿童罕见线粒体心肌病合并癫痫1例报告[J]. 临床儿科杂志, 2021, 39(7):546-548.
|
[8] |
李浩月, 薛亦男, 黄晨鸣. 线粒体脑肌病合并心肌病一例[J]. 中国心脏起搏与心电生理杂志, 2020, 34(3):309-311.
|
[9] |
Towbin JA, Jefferies JL. Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism[J]. Circ Res, 2017, 121(7):838-854.
doi: 10.1161/CIRCRESAHA.117.310987
pmid: 28912186
|
[10] |
Lee SR, Kim N, Noh YH, et al. Mitochondrial DNA, mitochondrial dysfunction, and cardiac manifestations[J]. Front Biosci (Landmark Ed), 2017, 22(7):1177-1194.
|
[11] |
Frazier AE, Thorburn DR, Compton AG. Mitochondrial energy generation disorders: Genes, mechanisms, and clues to pathology[J]. J Biol Chem, 2019, 294(14):5386-5395.
doi: 10.1074/jbc.R117.809194
pmid: 29233888
|
[12] |
Ng YS, Bindoff LA, Gorman GS, et al. Mitochondrial disease in adults: Recent advances and future promise[J]. Lancet Neurol, 2021, 20(7):573-584.
doi: 10.1016/S1474-4422(21)00098-3
pmid: 34146515
|
[13] |
Gorman GS, Chinnery PF, Dimauro S, et al. Mitochondrial diseases[J]. Nat Rev Dis Primers, 2016, 2:16080.
doi: 10.1038/nrdp.2016.80
pmid: 27775730
|
[14] |
Ng YS, Bindoff LA, Gorman GS, et al. Consensus-based statements for the management of mitochondrial stroke-like episodes[J]. Wellcome Open Res, 2019, 4:201.
doi: 10.12688/wellcomeopenres.15599.1
pmid: 32090171
|
[15] |
Mazzaccara C, Mirra B, Barretta F, et al. Molecular epidemiology of mitochondrial cardiomyopathy: A search among mitochondrial and nuclear genes[J]. Int J Mol Sci, 2021, 22(11):5742.
|
[16] |
Peoples JN, Saraf A, Ghazal N, et al. Mitochondrial dysfunction and oxidative stress in heart disease[J]. Exp Mol Med, 2019, 51(12):1-13.
doi: 10.1038/s12276-019-0355-7
pmid: 31857574
|
[17] |
Brunel-Guitton C, Levtova A, Sasarman F. Mitochondrial diseases and cardiomyopathies[J]. Can J Cardiol, 2015, 31(11):1360-1376.
doi: 10.1016/j.cjca.2015.08.017
pmid: 26518446
|
[18] |
Yang JO, Shaybekyan H, Zhao Y, et al. Case report: Whole exome sequencing identifies compound heterozygous variants in TSFM gene causing juvenile hypertrophic cardiomyopathy[J]. Front Cardiovasc Med, 2021, 8:798985.
|
[19] |
Wahbi K, Bougouin W, Béhin A, et al. Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases[J]. Eur Heart J, 2015, 36(42):2886-2893.
doi: 10.1093/eurheartj/ehv307
pmid: 26224072
|
[20] |
Linhart A. Metabolic Cardiomyopathy[M]. In: Baars HF, Doevendans PAFM,Houweling AC, et al. Clinical Cardiogenetics. Springer, Cham, 2020: 151-166.
|
[21] |
Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ. Human mitochondrial function during cardiac growth and development[J]. Mol Cell Biochem, 1998, 179(1-2):21-26.
pmid: 9543345
|
[22] |
中华医学会医学遗传学分会遗传病临床实践指南撰写组, 孙君慧, 韩帅, 等. 遗传性心肌病的临床实践指南[J]. 中华医学遗传学杂志, 2020, 37(3):300-307.
|
[23] |
Sabbah HN. Elamipretide for barth syndrome cardiomyopathy: Gradual rebuilding of a failed power grid[J]. Heart Fail Rev, 2022, 27(5):1911-1923.
|
[24] |
Karaa A, Bertini E, Carelli V, et al. Efficacy and safety of elamipretide in individuals with primary mitochondrial myopathy: The MMPOWER-3 randomized clinical trial[J]. Neurology, 2023, 101(3):e238-e252.
doi: 10.1212/WNL.0000000000207402
pmid: 37268435
|
[25] |
Meyers DE, Basha HI, Koenig MK. Mitochondrial cardiomyopathy: Pathophysiology, diagnosis, and management[J]. Tex Heart Inst J, 2013, 40(4):385-394.
pmid: 24082366
|
[26] |
Mancuso M, Orsucci D, Ienco EC, et al. Psychiatric involvement in adult patients with mitochondrial disease[J]. Neurol Sci, 2013, 34(1):71-74.
doi: 10.1007/s10072-011-0901-0
pmid: 22193419
|
[27] |
Holmgren D, Wåhlander H, Eriksson BO, et al. Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings[J]. Eur Heart J, 2003, 24(3):280-288.
doi: 10.1016/s0195-668x(02)00387-1
pmid: 12590906
|
[28] |
郭艺, 洪思琦, 蒋莉. 对线粒体医学会原发性线粒体病患者管理标准专家共识的解读[J]. 中国当代儿科杂志, 2018, 20(11):887-892.
|